A panel talks about changes in how drugs are marketed, from direct-to-consumer ads to patient education and support groups funded by pharmaceutical companies.

Guests

  • Dr. Adrian Di Bisceglie Medical director of the American Liver Foundation and professor of internal medicine at St. Louis University
  • Mary Nell Lenhard Senior vice president for policy and representation at the Blue Cross Blue Shield Association
  • Dr. Michael Shaw Executive director of EthicAd, a nonprofit group formed to create standards for direct-to-consumer drug ads
  • Dr. Thomas Murray Fellow at the Hastings Center

Related Links

Topics + Tags

Comments

comments powered by Disqus
Most Recent Shows